Advertisement
Screener

BioLineRx Ltd. (BLRX) Form 6-K: Report of foreign private issuer, 2023

BioLineRx Ltd. Form 6-K: Report of foreign private issuer

Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.

  • 2023-12-21: Form 6-K; Period of report 2023-12-21; Description 6-K; Document zk2330679.htm.
  • 2023-12-12: Form 6-K; Period of report 2023-12-12; Description 6-K; Document zk2330647.htm.
  • 2023-11-20: Form 6-K; Period of report 2023-11-20; Description 6-K; Document zk2330575.htm.
  • 2023-10-12: Form 6-K; Period of report 2023-10-12; Description 6-K; Document zk2330365.htm.
FiledFormPeriod of reportDescriptionDocument
2023-12-216-K2023-12-216-Kzk2330679.htm
2023-12-126-K2023-12-126-Kzk2330647.htm
2023-11-206-K2023-11-206-Kzk2330575.htm
2023-10-126-K2023-10-126-Kzk2330365.htm
2023-09-286-K2023-09-286-Kzk2330335.htm
2023-09-116-K2023-09-116-Kzk2330282.htm
2023-08-306-K2023-06-306-Kzk2330231.htm
2023-08-306-K2023-08-306-Kzk2330238.htm
2023-08-086-K2023-08-086-Kzk2330134.htm
2023-07-176-K2023-07-176-Kzk2329972.htm
2023-06-236-K2023-06-236-Kzk2329906.htm
2023-05-246-K2023-05-246-Kzk2329789.htm
2023-04-256-K2023-04-256-Kzk2329582.htm
2023-04-176-K2023-04-176-Kzk2329532.htm
2023-03-226-K2023-03-226-Kzk2329413.htm
2023-03-066-K2023-03-066-Kzk2329260.htm
2023-01-046-K2023-01-046-Kzk2328939.htm